Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies?

Karthaus, Meinolf; Rosenthal, Christoph; Ganser, Arnold

doi:10.1038/sj.bmt.1702024

Cited by 65 publications

(60 citation statements)

References 140 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…8,30 Although the patients in our study who had fever preprocedure had a higher rate of CAI, this difference did not reach statistical significance, in agreement with published literature. 2 Poor nutritional status has a known association with hematologic abnormalities 31,32 and puts patients at a greater risk of chemotherapy-induced neutropenia. 10 In addition, it has a negative impact on wound healing.…”

Section: Discussionmentioning

confidence: 99%

Severe neutropenia at time of port insertion is not a risk factor for catheter‐associated infections in children with acute lymphoblastic leukemia

Junqueira

Connolly

Abla

et al. 2010

Cancer

View full text Add to dashboard Cite

BACKGROUND:The objective of this study was to determine whether severe neutropenia on the day of port-a-catheter (PORT) insertion was a risk factor for catheter-associated infection (CAI) in children with acute lymphoblastic leukemia (ALL). METHODS: This was a retrospective study of children with ALL who had a PORT insertion between January 2005 and August 2008. Early ( 30 days) and late (>30 days) postprocedure complications were reviewed. The length of follow-up ranged between 7 months and 42 months. RESULTS: In total, 192 PORTs were inserted in 179 children. There were 43 CAIs (22%), and the infection rate was 0.35 per 1000 catheter-days. The CAI rate (15%) in children who had severe neutropenia on the day of the procedure did not differ statistically from the CAI rate (24%) in children who did not have severe neutropenia (P ¼ .137). Conversely, patients with severe neutropenia who had a CAI were more likely to have their PORT removed (P ¼ .019). The most common organisms to cause catheter removal were coagulase-negative Staphylococcus and Staphylococcus aureus. Patients with high-risk ALL had a statistically significant higher incidence of late CAI than patients with standard-risk ALL (P ¼ .012). Age (P ¼ .272), positive blood culture preprocedure (P ¼ 1.0), and dexamethasone use (P ¼ .201) were not risk factors for CAI. Patients who had an early CAI did not have a greater chance of having a late CAI. The catheter infection-free survival rate at 1 year was 88.6%. CONCLUSIONS: The current results indicated that severe neutropenia on the day of PORT insertion does not increase the risk of CAI in children with ALL. Cancer 2010;116:4368-75.

show abstract

Section: Discussionmentioning

confidence: 99%

Severe neutropenia at time of port insertion is not a risk factor for catheter‐associated infections in children with acute lymphoblastic leukemia

Junqueira

Connolly

Abla

et al. 2010

Cancer

View full text Add to dashboard Cite

show abstract

“…We have structured our manuscript-based thesis as follows: [6,[116][117][118]. Studies suggested the stages of progression of RIOM as initial hyperemia and erythema during the pre-ulcer phase where there is release of various pro-inflammatory cytokines from epithelial, vascular, and connective tissue cells at the site of tissue injury.…”

Section: Outlinementioning

confidence: 99%

Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis

et al. 2016

View full text Add to dashboard Cite

“…Common potentially severe side-effects related to 5-FU include diarrhea, mucositis/stomatitis [3], and leucopenia [4]. Cardiotoxicity is a relatively uncommon sideeffect of 5-fluorouracil and capecitabine.…”

Section: Introductionmentioning

confidence: 99%

Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene

Öfverholm¹,

Arkblad²,

Skrtic³

et al. 2010

Clinical Biochemistry

View full text Add to dashboard Cite

Objectives: Dihydropyrimidine dehydrogenase (DPD) is the initial rate-limiting enzyme in endogenous pyrimidine catabolism and is responsible for the reduction of the pyrmidine analog 5-fluorouracil (5-FU). DPD deficiency is known to cause potentially lethal toxicity in patients receiving 5-FU. Design and Methods:Restriction fragment length polymorphism (RFLP) and DNA sequence analysis were performed on genomic DNA and mRNA.Results: In 400 patients that were diagnosed with cancer and were eligible for 5-FU treatment, 14 patients were found to be heterozygous for the splice-site mutation DPYD IVS14+1G>A, which corresponds to a population frequency of 3.5%. Two novel variants in the DPYD gene were identified. The first case was heterozygous for DPYD c.1796T>C (p.M599T). In the second case, we observed heterozygosity for the splice-site mutation DPYD IVS14+17A>G. Conclusions:We report two new DPYD gene variants, of which DPYD c.1796T>C is potentially pathogenic, whereas DPYD IVS14+17A>G is suggested as a variant without clinical significance.

show abstract

Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies?

Cited by 65 publications

References 140 publications

Severe neutropenia at time of port insertion is not a risk factor for catheter‐associated infections in children with acute lymphoblastic leukemia

Severe neutropenia at time of port insertion is not a risk factor for catheter‐associated infections in children with acute lymphoblastic leukemia

Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis

Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene

Contact Info

Product

Resources

About